Produktneuigkeiten Hier finden Sie die neuesten Produktinformationen
-
Obtained CE-IVD marking for Anyplex™ MTB/NTMe Real-time Detection
Seegene has received CE-IVD mark under European Union on In Vitro Diagnostics Medical Devices for Anyplex™ MTB/NTMe Real-time Detection. This assay is a Real-time PCR assay to detect simultaneously Mycobacterium tuberculosis dissociated from non-tuberculosis mycobacteria and include whole process control for assay validity.
May 12, 2017｜ Anyplex™ MTB/NTMe Real-time Detection
-
Launched Anyplex™ II MTB/MDR/XDR Detection
Tuberculosis is caused by Mycobacterium tuberculosis infection and it’s mostly transmitted through the air. Recently, the number of drug- resistant mycobacterium tuberculosis has been increased in worldwide due to the spread of drug-resistant mycobacterium tuberculosis infection or improper treatment when tuberculosis is first diagnosed. The Anyplex™ II MTB/MDR/XDR Detection has been specifically designed to address this unmet medical need through the simultaneous detection, Screening of MTB, MDR-TB and XDR-TB contributing to TB infection. Based on Seegene’s proprietary DPO™ and TOCE™ technologies, this homogeneous assay performs on standard existing real-time PCR instrumentation to detect, MTB, 25 MDR mutations and 13 XDR mutations. This product can help you to properly manage the tuberculosis and provides effective treatment guidelinesAnyplex™ II MTB/MDR/XDR DetectionSimultaneous detection of MTB, MDR-TB and XDR-TBAnyplex™ II MTB/MDR/XDR Detection detects MTB, MDR-TB and XDR-TB in a single real-time PCR.
Sep 14, 2012｜ Anyplex™Ⅱ MTB/MDR/XDR Detection
-
Obtained CE-IVD marking for Anyplex™ plus MTB/NTM/DR-TB Detection
Anyplex™ plus MTB/NTM/DR-TB Detection Detection and discrimination of MTB/NTM & MDR-TB Seegene's Anyplex™ plus MTB/NTM/DR-TB Detection?has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.NOT AVAILABLE IN US
Nov 17, 2011｜ Anyplex™ plus MTB/NTM/DR-TB Detection
-
Launched Magicplex™ TB/MDR Real-time Test
Magicplex™?TB/MDR Real-time TestMagicplex™ TB/MDR Real-time Test detects Mycobacterium tuberculosis (MTB) and screens Multidrug-resistant Mycobacterium tuberculosis (MDR-TB) on Real-time PCR.NOT AVAILABLE IN US
Dec 01, 2010｜ Magicplex TB/MDR Real-time Test
-
Obtained CE-IVD marking for Magicplex™ MTB Real-time Test
Detection of Mycobacterium tuberculosis Seegene's Magicplex™ MTB Real-time Test?has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.NOT AVAILABLE IN US ? ? ?
Aug 16, 2010｜ Magicplex MTB Real-Time Test
-
Obtained CE-IVD marking for Anyplex™ MTB/NTM Real-time Detection
Anyplex™ MTB/NTM Real-time DetectionIdentification of MTB dissociated from NTM Seegene's Anyplex™ MTB/NTM Real-time Detection has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.NOT AVAILABLE IN US
Jul 12, 2010｜ Anyplex™ MTB/NTM Real-time Detection
-
Launched Magicplex™ MTB Amplification
Magicplex™ MTB Amplification1 Detection of MTB1Using READ™ technology, this product simultaneously detects both IS6110 and MPB64 genes in tuberculosis bacilli and tests for Mycobacterium tuberculosis (MTB), through Real-time PCR.Testing for IS6110 & MPB64 genes IS6110 is an insertion sequence present in the MTB genome. As most MTB have one to twenty copies of it, its presence is a useful indicator in tuberculosis tests. There have, however, been reports of MTB strains without this gene, and in such a case, the accuracy of diagnosis can be enhanced by testing simultaneously for IS6110 and MPB64, which is a conserved sequence present in single copy in the MTB genome. This product is designed to detect both genes, significantly improving sensitivity. Molecular detection of MTB Acid-fast bacilli (AFB) smears and culture tests have been conventionally used in the diagnosis of tuberculosis. Although AFB smears are simple and fast, they suffer from low sensitivity and specificity; culture tests are the most accurate among the standard methods, but take a long time, approximately 8 weeks, to produce results. On the other hand, nucleic acid amplification, which has emerged recently as a promising method with the advances in molecular diagnostic technology, detects MTB directly from the sample, and it is being used widely due to its high sensitivity and its ability to produce results quickly. NOT AVAILABLE IN US
Feb 07, 2010｜ Magicplex MTB Amplification
